baber/WOPTO huggingface dataset:
Patent IL-96341-A0 (IL)
Title: Adjustable nozzle assembly
IPC: B05B1/34
Filed: 1990-11-13
Abstract: The adjustable nozzle assembly for a trigger sprayer comprises a nose bushing and an integral nozzle cap capable of being screwed upon the bushing. The nozzle cap has a discharge orifice located in its front face and a flange skirt extending from a front wall thereof. A nozzle cap flange skirt is threaded inside the rear portion thereof and an internally contoured or stepped surface is located forwardly of the threads to provide reduced diameter annular surfaces at two locations rearward of an inner wall surface of the cap and forward of the internal threads inside the nozzle cap flange skirt. The nozzle cap is screwed upon (threaded on) an externally threaded portion of the nose bushing and is selectively threadably positionable between three selective positions such that the positioning of the inner wall surface and the annular surfaces of the nozzle cap flange skirt selectively cooperate with a front face and annular periphery of a nose bushing face disc having two angular grooves in the annular periphery thereof thereby selectively to provide a stop mode position for containment of liquid, a spray mode position to discharge liquid in a spray pattern from the discharge orifice, and a stream mode position to discharge liquid in a stream pattern from the discharge orifice.
Patent AU-PQ846900-A0 (AU)
Title: A vaccine
IPC: A61P31/00
Filed: 2000-06-29
Abstract: The present invention relates to a method for reducing the occurrence and severity of infectious diseases, especially infectious diseases in which lipid-containing infectious organisms are found in biological fluids, such as blood. The present invention employs solvents useful for extracting lipids from the lipid-containing infectious organism, thereby reducing the infectivity of the infectious organism. The present invention also provides a vaccine composition, comprising a lipid-containing infectious organism, treated with solvents to reduce the lipid content of the infectious organism, combined with a pharmaceutically acceptable carrier. The vaccine composition is administered to an animal or a human to provide protection against the lipid-containing infectious organism.
Patent FI-20031492-A0 (FI)
Inventor: AROMAA SAMI
IPC: H04B1/10
Filed: 2003-10-13
Abstract: Method for suppressing interference and arrangement for same, and radio communications receiver. The method includes: computing at least one transform of a received, analogue-to-digital converted radio signal; computing metrics defining the concentration of the interference present both for the transformed radio signal and the non-transformed radio signal; selecting the transform whose metrics indicate the highest concentration of the interference in the transfer domain as the transform to be used, or selecting no transform if the metrics indicate the highest concentration of the interference for the non-transformed signal; suppressing the localized interference from the transformed radio signal by using weighting and computing inverse transform of the transformed radio signal if the transform was selected, or suppressing the localized interference from the non-transformed radio signal by using weighting if no transform was selected; and detecting and decoding the interference suppressed radio signal.
Patent IL-100010-A0 (IL)
Title: Avirulent strain of salmonella typhi,its preparation and vaccines containing it
IPC: C12N5/10
Filed: 1991-11-08
Abstract: This invention provides immunogenic compositions for the immunization of a vertebrate or invertebrate comprising an avirulent derivative of S. typhi. The derivatives having a mutation of the cya and/or crp and/or cdt genes. The invention also provides immunogenic compositions for the immunization of a vertebrate and invertebrate comprising an avirulent derivative of the above type which is capable of expressing a recombinant gene derived from a pathogen of said vertebrate or invertebrate individual to produce an antigen capable of inducing an immune response against said pathogen. Other embodiments of the invention include methods of preparing immunogenic compositions from these strains, and strains useful in the preparation of the immunogenic compositions, as well as methods of stimulating the immune system to respond to an immunogenic antigen of S. typhi by administration of the immunogenic composition.
Patent IL-112518-A0 (IL)
Title: Thyroid hormone fast dispersing pharmaceutical composition
IPC: A61K31/195
Filed: 1995-02-01
Abstract: PCT No. PCT/EP95/00321 Sec. 371 Date Jul. 31, 1996 Sec. 102(e) Date Jul. 31, 1996 PCT Filed Jan. 30, 1995 PCT Pub. No. WO95/20953 PCT Pub. Date Aug. 10, 1995There is disclosed a solid fast dispersing dosage form of a pharmaceutical composition suitable for oral administration comprising: a therapeutic agent which comprises one or more compound thyroid hormone or hormones; from about 80% to about 99.9% of disintegrating agent by mass; from about 0.01% to about 10% of flavoring agent by mass; and from about 0.1% to about 5% mass of lubricating agent by mass; which has utility in the treatment of disorders associated with the improvement of the thyroid hormone function in animals including human beings.
Patent IL-115199-A0 (IL)
Title: Nucleic acid delivery vehicle
IPC: A61K38/37
Filed: 1995-09-07
Abstract: A composition includes a liposome which has a polynucleic acid and a peptide capable of disrupting membranes under acidic conditions encapsulated within it. The composition is used for efficient transfer of nucleic acids into cells both in vitro as well as in vivo.
Patent IL-118942-A0 (IL)
Title: Avirulent herpetic viruses useful as tumericidal agents and vaccines
IPC: C12N7/00
Filed: 1996-07-24
Abstract: Isolated tumoricidal herpetic viruses, in particular neurotrophic herpes viruses, T-lymphotrophic viruses, and B-lymphotrophic viruses, which are avirulent and capable of selectively replicating in and destroying neoplastic cells, and pharmaceutical compositions, vaccines, and methods of destroying neoplastic cells employing the isolated tumoricidal herpetic viruses are described. A method of isolating tumoricidal herpetic viruses by sequentially passaging attenuated, avirulent herpetic viruses on neoplastic cells which fail to support replication of the herpetic viruses and isolating the viruses which grow on the neoplastic cells is also described. Herpes simplex virus mutants having a genome from which the  gamma 34.5 genes have been deleted and which require at least one additional mutation to produce a non-neurovirulent herpes simplex virus which selectively replicates in and destroys neoplastic cells are also described.
Patent IL-120858-A0 (IL)
Title: Magnetic flow controller
IPC: F16K31/02
Filed: 1997-05-19
Abstract: PCT No. PCT/IL97/00289 Sec. 371 Date Aug. 18, 1998 Sec. 102(e) Date Aug. 18, 1998 PCT Filed Sep. 1, 1997 PCT Pub. No. WO98/53233 PCT Pub. Date Nov. 26, 1998An electromagnetic flow control apparatus includes a fluid flow conduit, a magnetic membrane, and a plurality of discrete sources of selectably variable magnetic fields, such as electromagnets, arranged in an ordered array, to drive the membrane in a desired manner to control the flow of fluid in the conduit. The membrane can preferably be driven between two extreme positions wherein the flow of fluid in the conduit is totally unrestricted in the rest position of the membrane and wherein the flow is highly restricted or stopped completely in the maximum deformation of the membrane radially inward.
Patent IL-122558-A0 (IL)
Title: Granulation method and apparatus therefor
IPC: C05G5/30
Filed: 1997-04-09
Abstract: An apparatus and method for uniform granulation is disclosed. The method involves the use of an initial feedstock having particle size of -150 mesh and 90% or greater particle size of 200 mesh. The feedstock may be contacted in a pan granulator which includes a minor amount of nucleating material of about -35 mesh. Binder is introduced into the pan granulator to progressively layer the feedstock material onto the nucleating to form a final product having a size distribution -8 mesh to +4 mesh. The method is designed to be interruptible and is particularly useful for forming granules having a plurality of layers of differing material. The method has marked improvement over the prior art methods since a particularly fine granule can be formed in a relatively expedient process to result in a granule having high commercial value and high break strength. These factors are achievable in addition to 100% product usage with no waste.
Patent IL-125939-A0 (IL)
Title: Protein tyrosine phosphatases of hematopoietic cells
IPC: A61P43/00
Filed: 1997-03-17
Abstract: This invention concerns new non-receptor protein tyrosine phosphatases of the hematopoietic stem cells (PTP HSC). The invention specifically concerns native murine and human PTP HSCs, their analogs in other mammals, and their functional derivatives. The invention further relates to nucleic acid encoding these proteins, vectors containing and capable of expressing such nucleic acid, and recombinant host cells transformed with such nucleic acid. Assays for identifying agonists and antagonists of the native PTP HSCs, methods for expansion of undifferentiated stem cells, and methods for the induction of stem cell differentiation are also within the scope of the invention.
Patent IL-126237-A0 (IL)
Title: Stabilizing compositions
Inventor: BECHTOLD KARL
IPC: C08K5/00
Filed: 1997-04-10
Abstract: PCT No. PCT/IB97/00388 Sec. 371 Date Oct. 13, 1998 Sec. 102(e) Date Oct. 13, 1998 PCT Filed Apr. 10, 1997 PCT Pub. No. WO97/39051 PCT Pub. Date Oct. 23, 1997The invention relates to novel compositions of photoreactive, UV-light absorbing, low molecular weight polyalkylpiperidines and non-photoreactive low molecular weight sterically hindered polyalkylpiperidines as well as to masterbatch compositions comprising the novel compositions. The invention relates further to a process for enhancing the light stability of organic material, the stabilized organic material and its use.
Patent IL-144403-A0 (IL)
Title: Methods and devices for delivery of agents to breast milk ducts
IPC: G01N33/48
Filed: 2000-01-25
Abstract: The invention provides devices, kits and methods for delivering an agent to a breast milk duct. Intraductal agent delivery provides an opportunity to treat a breast condition locally and avoid the pitfalls of systemic drug delivery for a local condition. Time-released agents delivered into the ducts using an intraductal device or formulation reduces the frequency of intraductal administration required for desired efficacy over time. The methods include methods of treating a breast condition, including the conditions of cancer or precancer.
Patent IL-159661-A0 (IL)
Title: Reservoir module with a piston rod
IPC: A61M5/00
Filed: 2002-07-22
Abstract: A product dispensing apparatus including a reservoir module, a dosing module and a dose setting member. The reservoir module includes a front casing section, a block, a first connector, a piston, and a piston rod moveable in a dispensing movement and against the dispensing movement, and including a return block engageable with the block, wherein engagement between the block and the return block prevents the piston rod from moving against the dispensing movement. The dosing module includes a rear casing section, including a second connector which is engageable with the first connector to form a detachable connection between the reservoir module and the dosing module, and a dosing and drive device. The dose setting member engages the piston rod such that it is moveable together with and in the same direction as the piston rod during the dispensing movement and is moveable relative to the piston rod against the dispensing movement.
Patent IL-164802-A0 (IL)
Title: Stable adenoviral vectors and methods for propagation thereof
IPC: C12N15/09
Filed: 2003-04-24
Abstract: Provided are methods and means to increase the stability and/or the packaging capacity of recombinant adenoviruses, by overexpression of pIX in an adenoviral packaging cell, by retaining at least a part of the E1B-55K region in the recombinant adenoviral vector or by regulating pIX with a heterologous promoter. The invention further relates to methods and means for the production of such adenoviruses on complementing cell lines, wherein the early region 4 open reading frame 6 (E4-orf6) encoding nucleic acid is present in the adenovirus and wherein the E4-orf6 gene product is compatible with one or more products of the E1 gene products in the complementing cell, such that the adenoviral vector can be efficiently produced by the complementing cell.
Patent IL-174743-A0 (IL)
Title: Apparatus and method of direct mode radio communication
IPC: H04W84/08
Filed: 2006-04-03
Abstract: A method of direct mode radio communication is disclosed, characterised by a mobile station (MS) maintaining at least a first direct mode group set (DGS) comprising an ordered list of two or more user groups together with their respective associated direct mode radio frequency (RF) channels. The groups are maintained for the purpose of scanning for alternative RF activity among some or all of said groups.
Patent IL-182740-A0 (IL)
Title: Fluoridation process
IPC: C07H13/04
Filed: 2007-04-23
Abstract: The invention relates to an improved process for the fluoridation of sugar derivatives in which a controlled amount of water is present in the solvent.
Patent IL-192972-A0 (IL)
Title: Genetically engineered attenuated influenza viruses and methods for preparation thereof
IPC: C12N7/01
Filed: 2008-07-22
Abstract: The present invention relates to engineering attenuated viruses by altering a non-coding region or the coding sequence of a viral gene. Alterations of the non-coding regions which regulate transcription and/or replication are described. These alterations result in the down-regulation of the viral gene and an attenuation of the virus, either by the production of defective particles during replication, or by reducing the number of progeny virions produced during viral replication. Alterations of viral coding sequences are also described which result in a recombinant or chimeric attenuated virus.
Patent RO-126137-A0 (RO)
Title: Rotary piston machine
Inventor: STAN GHEORGHE
IPC: F02B53/00
Filed: 2010-10-29
Abstract: The invention relates to a rotary piston machine which can be called a cam-type piston, said machine converting the mechanical work taken over from a driving shaft for generating a pressure in a fluid and usable as a pump or usable as a pneumatic, hydraulic or heat engine by introducing a pressurized fluid for carrying out a mechanical work in said shaft. According to the invention, in a fifth embodiment, the machine usable as two-cycle engine is provided with a rotary piston (56) having a curvilinear outline and being integral with a shaft (57), both elements rotating in a cylindrical housing (58) closed by means of some covers (59 and 60), the working areas being divided by some sealing elements ( Ω ), which are kinematically linked to the rotary piston (56) by some ring-holder frames (65) and some guiding channels (a and b), symmetrically cut on the two surfaces thereof, following its outer profile, the rotary piston (56) being provided with some inner chambers (g, h and i) manufactured so as to obtain its statical and dynamical balance, and the sealing elements ( Ω ) being provided with some double spacers (66 and 67) and a wearing ring (68), said element being maintained in contact with the working area of the rotary piston (56) by means of some curvilinear areas (j and k) made in the spacers (66 and 67) and the ring-holder frame (65).
Patent RO-129954-A0 (RO)
Title: Method for identifying liquids in recipients
Inventor: IOVEA MIHAI
IPC: G01N23/10
Filed: 2014-05-07
Abstract: The invention relates to a method for identifying liquids in recipients meant to check the recipients filled with liquids, aerosols and gels in airports. According to the invention, the method is based on the analysis of the recipient projections on the radiographic image when the recipient is scanned by means of X-rays and consists of the emission of some fan-like radiations, by means of two sources () of X radiation, which are recorded by two detectors (), then from the radiographic image obtained by the first detector (), some areas () are set, by means of which the thickness of the recipient walls is calculated, and an area () by means of which the liquid thickness is calculated, afterwards, once these thicknesses are calculated, the data are transmitted to the second detector () where they are processed.
Patent RO-131946-A0 (RO)
Title: Tetrapyrrolic compound with applications in theranostics and process for preparing the same
Inventor: BOSCENCU RICA
IPC: A61K31/24
Filed: 2016-11-28
Abstract: The invention relates to a tetrapyrrolic compound with applications in diagnosis and therapy of solid tumours and to a process for preparing the same. According to the invention, the compound is 5,15-bis-(4-hydroxy-3-methoxyphenyl)-10,20-bis-(4-carboxymethylphenyl)porphirine, presented as purple crystals which are insoluble in water and soluble in methylene chloride, ethyl alcohol, isoproyl alcohol, dimethyl sulphoxide, polyethylene glycol 200 and, due to its properties, it can simultaneously achieve solid tumours diagnosis and therapy. The preparation process, as claimed by the invention, comprises the interaction, under the action of microwaves, of a mixture consisting of 4-hydroxy-3-methoxybenzaldehyde, methyl-4-formyl benzoate and pyrrole on a neutral aluminium oxide carrier, the dissolution of the resulting product in dichloromethane/ethyl ether, filtration and concentration of the said solution by distillation, followed by the purification of the asymmetrical tetrapyrrolic compound by chromatography.
Patent RO-132372-A0 (RO)
Title: Acetabular milling device
Inventor: NICULESCU MARIUS
IPC: A61F2/46
Filed: 2017-09-18
Abstract: The invention relates to an orthopedic milling device intended to remove osteophytes without the risk of breaking the acetabular part of a hip endoprosthesis, meant to be applied in the field of orthopedic surgery. According to the invention, the device comprises a collecting cup (1) and a face milling cutter (2), assembled by means of a quickly-interchangeable bushing (3), the milling cutter (2) having a central rod (4) provided with some orifices, which is screwed into the collecting cup (1) and locked for setting the machining zero level, by a locking screw (5), two attachment rings (6 and 8), namely an external one and an internal one, respectively, a helical spring (7), a main body (9) and an operating key (10).
Patent AP-2000001846-A0 (AP)
Title: Triazine compounds for treatment of CNS disorders.
Inventor: COX BRIAN
IPC: A61P25/04
Filed: 1998-12-18
Abstract: A compound of formula (i)and pharmaceutically acceptable prodrugs, salts and solvates thereof.
Patent ZW-4293-A1 (ZW)
Title: Co-polymers
Inventor: MICHAEL ALVERT DEREK SIMPSON
IPC: C08F290/00
Filed: 1993-03-18
Abstract: An amphipathic co-Polymer having a weight average molecular weight of from 2,500 to 20,000 inclusive and comprising an addition polymer backbone and at least one C1-4 alkoxy polyethylene or Polyethylene copropylene glycol acrylate or methacrylate stabilizer unit where the backbone comprises up to 30% by weight of non-functional structural units and at least 70% by weight in total of stabilizer units and functional units where the functional units are optionally substituted styrene-containing units, hydroxy group-containig units and carboxyl group containing units, such that the proportions of hydroxy groups to carboxyl groups to styrene groups to propylene-oxy or ethylene-oxy groups are respectively 1 : 0.10-26.1; 0.28-25.0; 0.80-66.1.
Patent MA-27657-A1 (MA)
Title: Derives substitues du 3-(benzoylureido) thiophene, leur procede de preparation et leur utilisation
Inventor: SCHOENAFINGER KARL
IPC: C07D409/04
Filed: 2005-08-16
Abstract: L'invention concerne des composés de formule (I), dans laquelle les résidus ont une signification spécifiée, ainsi que leurs sels physiologiquement compatibles. Lesdits composés sont utilisés en tant que médicaments utilisés pour prévenir et traiter le diabète de type 2.
Patent MA-38412-A1 (MA)
Title: Dispositifs dentaires, et leurs systèmes et procédés de fabrication
Inventor: GINSBURG STEPHEN
IPC: A61C13/34
Filed: 2014-03-12
Abstract: L'invention concerne des dispositifs dentaires, et leurs systèmes et procédés de fabrication. Dans au moins un mode de réalisation, l'invention concerne un procédé pour fabriquer un dispositif en forme d'arcade à accoupler à la bouche d'un patient. Le procédé peut comprendre la disposition de chacune d'une pluralité de dents dans des récepteurs de dent respectifs d'un dispositif d'encastrement, le positionnement du dispositif d'encastrement dans une cavité d'une partie inférieure d'un dispositif de moule, et l'accouplement de la partie inférieure à une partie supérieure du dispositif de moule pour prendre en sandwich le dispositif d'encastrement entre elles. Le procédé peut également comprendre l'injection d'un composé de base dans un trou d'injection du dispositif de moule, et le traitement du composé de base pour intégrer le composé de base à la pluralité de dents.
Patent UY-27128-A1 (UY)
Title: L-aspartato de sertralina, algunas otras sales derivadas, composiciones farmacéuticas que las contienen y procedimientos de preparación
Inventor: SHANKER RAVI MYSORE
Filed: 2002-01-21
Abstract: Refiere L-aspartato de sertralina, composiciones que lo contienen y procedimientos para su preparación.
Patent UY-28553-A1 (UY)
Title: Solución de agente tensoactivo que contiene óxido de zinc
Inventor: PAYE MARC
IPC: A61K8/40
Filed: 2004-10-08
Abstract: Se revela una composición de limpieza para limpiadores de propósito general, líquidos de trabajo liviano, champúes, banos de espuma, jabones líquidos para las manos, detergentes para tela delicada, productos líquidos para la limpieza de piel, pastas lavaplatos, barras de jabón lavaplatos y geles para la ducha, la cual incluye al menos un agente tensoactivo, óxido de zinc que tiene un tamano de partícula de 10 a 30 nm, y agua.
Patent UY-30629-A1 (UY)
Title: Nuevo péptido de actinomadura namibiensis
Inventor: MEINDL DR KATHRIN
IPC: A61K31/00
Filed: 2007-10-04
Abstract: La invencion se refiere a un compuesto de la formula (I) en la que m y n son, independientemente entre sí, 0, 1 o 2, que puede obtenerse a partir de Actinomadura namibiensis (DSM 6313), a su uso para el tratamiento de infecciones bacterianas, infecciones virales y/o dolor y a una composicion farmacéutica que lo comprende.
Patent UY-31770-A1 (UY)
Title: Inhibidores de catepsina c
Inventor: JEAN EMILIE VERONIQUE PETIT
IPC: A61P29/00
Filed: 2009-04-16
Abstract: Un compuesto de fórmula (IA) o (IB) y su utilización para tratar enfermedades inflamatorias tales como COPD.